Evoke Pharma Inc Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Evoke Pharma Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2013 to Q1 2024.
  • Evoke Pharma Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $7.54M.
  • Evoke Pharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$119K, a 102% decline from 2022.
  • Evoke Pharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.29M, a 45.7% decline from 2021.
  • Evoke Pharma Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $13.4M, a 48.6% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.54M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2022 $172K -$12.9M -98.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $13.1M +$13M +61407% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $21.3K -$615K -96.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $636K +$91.8K +16.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $545K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2014 -$361K -$2.36M -118% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q1 2013 $2M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.